Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-201-1 | CAS number: 3030-47-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study, with acceptable restrictions (14-day-exposure only)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1988
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 412 (Subacute Inhalation Toxicity: 28-Day Study)
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- PMDETA
- IUPAC Name:
- PMDETA
- Test material form:
- other: vapour
- Details on test material:
- Pale yellow liquid
Molecular Weight: 173.3 daltons
Boiling Point: 203.5 °C
Vapor Pressure: 0.422 mmHG @ 2S°C
PMDETA was obtained from the BASF Corporation, Parsippany, New Jersey (Lot #6872641).
Analysis by GC-MS and infrared spectroscopy conducted by the analytical laboratories of the Dow Chemical Company, Midland, Michigan.
The compositional analysis :
N,N,N',N",N´´-Pentamethyldiethylenetriamine 99.1 %
tetramethyldiethylenetraimine (2 isomers) 0.4%
N,N,N´-trimethylethylenediamine 0.1 %
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Source: B Charles River Breeding Laboratories, Inc., Kingston, New York.
Acclimating period: 2 weeks prior to exposure
Water and Purina Certified Rodent Chow tf5002 (Riilston Purina Co., St. Louis, Missouri) available ad libitum, except during exposures.
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- Rats (5/sex/exposure group)
Exposure: 6 hours/day, 5 days/week.
Number of exposures: 9 exposures in the 0, 3, and 12 ppm groups; 5 exposures in the 48 ppm group.
Chamber airflow maintained at approximately 225 liter/minute.
The air supplied to the chambers controlled by a system designed to maintain temperature at approximately 22°C and relative humidity at approximately 50%.
The temperature and relative humidity in each chamber were recorded approximately hourly during each exposure period.
Vapors of the liquid test material were generated using a J-tube assembly as described by Miller et al. (1980). - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The nominal concentration was calculated for each chamber on a daily basis. The analytical chamber concentrations were determined at least 3 times/ exposure period by GC with a flame ionization detector (Varian 1400, Palo Alto, California).
The GC conditions were nitrogen flow = 100 ml/minute, hydrogen flow = 30 ml/minute, and air flow = 300 ml/minute.
A 6' x 1 /8" stainless steel column packed with 10% OV-11 on 100/120 Supelcoport (lot # F16243) was used to separate the test material from air. - Duration of treatment / exposure:
- 6 hours / day
- Frequency of treatment:
- 5 days / week, 2 weeks
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0,3,12, or 48 ppm (0,21,85, or 340 mg/m3)
Basis:
analytical conc.
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- Duration of exposure - up to 14 days
- Frequency of observations: daily
- Examinations performed: necropsy, histopathology of major organs and tissues, urinalysis, hematology, and clinical chemistry determinations, body weights, major organs weighed. - Positive control:
- ---
Examinations
- Observations and examinations performed and frequency:
- All rats were observed after each exposure period for changes in appearance and overt signs of toxicity.
The observations included evaluation of the eyes, skin, fur, mucous membranes, and respiration. Behavior pattern and nervous system activity was assessed by specific observation for salivation, lacrimation, diarrhea, tremors, convulsions, lethargy, and other signs of central nervous system depression. Records of mortality were maintained. An additional daily observation and observations on weekends
were made. The laboratory veterinarian conducted a pen-light ophthalmological examination on each animal from all exposure groups prior to initiation of exposures and immediately prior to necropsy of animals in the 0,3, and 12 ppm exposure groups. All surviving rats were weighed on
test days 1,3,5,8, and 11 except male and female rats exposed to 48 ppm which were sacrificed on day 8 because of poor clinical condition. - Sacrifice and pathology:
- Rats exposed to 0,3, or 12 ppm PMDETA were fasted overnight and sacrificed the day following the last exposure.
Major organs were weighed and tissues evaluated histopathologically. Appropriate samples for urinalysis, hematology, and clinical
chemistry determinations were obtained, body weights recorded, major organs weighed, and tissues were collected for histologic examination.
Nonfasted rats exposed to 48 ppm PMDETA were anesthetized, sacrificed, and necropsied prior to the sixth exposure; blood samples for clinical laboratory determinations, body weights, and organ weights were not obtained. - Other examinations:
- Blood samples were obtained by orbital sinus puncture from all surviving rats under slight methoxyflurane anesthesia immediately prior to
necropsy.
Urine was obtained from all rats exposed to 0,3, or 12 ppm PMDETA during the second week of exposure and evaluated for color and
character. - Statistics:
- All parameters examined statistically were tested for equality of variances using Bartlett's test. Then, one-way and two-way ANOVA and three-way repeated measures ANOVA were used.
Descriptive statistics (means and SD) were reported for chamber concentrations, temperature, relative humidity, and WBC differential counts.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- irritation of tissues in a direct contact with the test material
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- irritation of tissues in a direct contact with the test material
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- effects observed, treatment-related
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Description (incidence and severity):
- Differences were due to decreased mean final body weight in animals.
- Gross pathological findings:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- irritation of nasal cavity, skin and cornea
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- ANIMAL OBSERVATIONS:
All rats exposed to 3 ppm survived until termination of the study with no indication of clinical signs as a result of the exposures.
All rats exposed to 12 ppm developed unilateral or bilateral cloudy corneas by test day 5 and these changes persisted throughout
the study.
Following exposure to 48 ppm on test day I, all rats had bilateral cloudy corneas. Most of these rats, after subsequent exposures, developed chromodacryorrhea and swollen, hyperemic ear pinnae with superficial incrustations. Animals from this exposure group were sacrificed
on test day 8 (following 5 exposures) because of their poor physical condition.
BODY WEIGHTS:
The body weights of rats exposed to 3 ppm were comparable to respective control values. An exposure-related time-dose interaction for both
males and females was statistically identified for the 12 and 48 ppm exposure groups. The mean body weights of male rats exposed to 12 ppm were decreased approximately 10% from the corresponding control male value on test day 5 and by test day 11, the difference was approximately 13%.
The mean body weights of male and female rats exposed to 48 ppm were decreased from corresponding control values beginning on test day day 3 and by test day 8, male body weight was decreased approximately 29% from controls while females were decreased approximately 25%.
ORGAN WEIGHTS:
Differences in organ weights were due to decreased mean final body weight in animals.
PATHOLOGY:
Exposure-related gross changes occurred in male and female rats exposed to 12 or 48 ppm while rats exposed to 3 ppm were similar to controls.
Rats exposed to 12 ppm had bilateral cloudy corneas. The 48 pprn exposure group was necropsied on test
day 8 because of their poor physical condition and one female rat from this exposure group was found dead on test day 7. Gross pathologic changes were bilateral cloudy corneas, decreased fat in the abdominal cavity, crusts on the external nares and ear pinnae, and bilateral chromodacryorrhea.
HISTOPATHOLOGY:
Exposure-related and concentration-dependent microscopic changes occurred in the nasal cavity of male and female rats exposed to 3, 12, or 48 ppm, mainly vacuolar degeneration of respiratory epithelium and the underlying submucosal glands. Rats exposed to 12 ppm had vacuolar degeneration of respiratory epithelium and vacuolar degeneration of olfactory epithelium. Additionally, there was vacuolar degeneration of submucosal glands beneath both types of epithelia and the epithelium lining the floor of the anterior portion of the nasopharynx. Several male and female rats in this exposure group had more severe morphologic damage to the nasal cavity as indicated by rnultifocal erosions of respiratory epithelium and inflammatory exudate into the nasal meati. Microscopic changes in the nasal cavities of rats exposed to 48 ppm were vacuolar degeneration of respiratory and submucosal glands throughout all 4 levels of the nasal cavity. There were also extensive areas of erosions, necrosis, and squamous metaplasia of respiratory epithelium. Vacuolar degeneration of nasopharyngeal epithelium extended throughout the nasopharynx.
No additional target organs were identified after microscopic examination of tissues from rats exposed to 3 ppm; however, exposure-related microscopic changes in tissues from rats exposed to 12 or 48 ppm included the eyes, skin, larynx (48 ppm only), trachea (48 ppm only), and bronchi (48 ppm only). Ocular changes were vacuolar degeneration of corneal epithelium.
Effect levels
open allclose all
- Dose descriptor:
- conc. level: 3 ppm
- Effect level:
- 3 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: localised irritation of nasal cavity
- Dose descriptor:
- conc. level: 12 ppm
- Effect level:
- 12 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: local irritation of nasal cavity, skin and cornea
- Dose descriptor:
- conc. level: 48 ppm
- Effect level:
- 48 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: body weight loss, poor clinical condition, extensive irritation of upper respiratory tract, skin and eyes.
- Dose descriptor:
- LOAEC
- Remarks:
- local
- Effect level:
- 3 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- The morphologic appearance of the histopathologic changes was primarily characterized as vacuolar degeneration of epithelium lining the
airways and covering the cornea or skin (superficial layers of the epidermis).
Observed changes were indicative of nonselective localized irritation to tissues at risk by exposure to sufficient
vapor concentrations of the test material. Even at the highest concentration tested (48 ppm), there was no indication of damage to organs or
tissues that were not directly exposed to PMDETA vapors.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.